|
Sprout Growth II LP
|
|
|
Fund Closing
Active |
|
|
|
Stonington Capital Appreciation 1994 Fund LP
|
United States |
|
Fund Closing
Active |
|
|
|
Ta XI LP
|
United States |
31 Dec 2010 |
Fund Closing
Active |
|
|
|
Thomas H Lee Equity Fund V LP
|
United States |
31 Dec 2001 |
Fund Closing
Active |
|
|
|
Thomas H Lee Equity Partners VI LP
|
United States |
31 Dec 2007 |
Fund Closing
Active |
|
|
|
TowerBrook Investors III LP
|
United States |
|
Fund Closing
Active |
|
|
TPG Partners V LP
|
United States |
31 Dec 2006 |
Fund Closing
Active |
|
|
|
Valentis
Biopharmaceuticals company in the fields of cardiovascular disease, oncology, and infectious diseases. |
United States |
|
N/A
Active |
|
|
|
Venture Investors of Wisconsin Inc
|
United States |
|
N/A
Active |
|
|
Warburg Pincus Private Equity IX LP
|
United States |
31 Dec 2005 |
Fund Closing
Active |
|
|
Warburg Pincus Private Equity X LP
Private Equity Fund |
United Kingdom |
1 Apr 2008 |
Fund Closing
Active |
|
|
|
WLR Recovery Fund LP
|
United States |
|
Fund Closing
Active |
|
|
ZyStor Therapeutics Inc
|
United States |
16 Dec 2004 |
Series A
Initial investment. Round participant. Active |
|